Heteroaryl derivatives useful to inhibit chk1 urea.

Compound which is 1- [5-bromo-4-methyl-2-S- (morpholin-2-ylmethoxy) -phenyl] -3- (5-methyl-pyrazin-2-yl) -urea or a pharmaceutically acceptable salt of the same.